Apricus Biosciences, Inc.
Apricus Biosciences Announces Corporate Update and Third Quarter 2017 Financial Results Conference Call
SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus' third quarter 2017 financial results will be released on Thursday, November 2, 2017 at 4:01 p.m. Eastern Time. Company management will host a conference call on Thursday, November 2, 2017, at 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.
To participate by telephone, please dial (855) 780-7196 (Domestic) or (631) 485-4867 (International). The conference ID number is 8498419. The live audio webcast can be accessed via the Investor Relations' section of Apricus' website at www.apricusbio.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for 30 days following the live call.
About Apricus Biosciences, Inc .
Apricus Biosciences, Inc. (APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus has two product candidates currently in development. Vitaros is a product candidate in the United States for the treatment of erectile dysfunction, which is in-licensed from Warner Chilcott Company, Inc., now a subsidiary of Allergan plc (Allergan). RayVa is our product candidate in Phase 2 development for the treatment of the circulatory disorder Raynaud's phenomenon, secondary to scleroderma, for which we own worldwide rights.
For further information on Apricus, visit http://www.apricusbio.com.
Vitaros(TM) is Apricus' trademark in the United States, which is pending registration and subject to the agreement with Allergan. Vitaros® is a registered trademark of Ferring International Center S.A. in certain countries outside of the United States. RayVa(TM) is Apricus' trademark, which is registered in certain countries throughout the world and pending registration in the United States.
The Trout Group
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Glatfelter23.10.2018 16:39 | pressemeddelelse
Glatfelter’s Composite Fibers Business Unit Announces 7% Price Increase
Hitachi Vantara Corporation23.10.2018 15:01 | pressemeddelelse
Hitachi Vantara Completes REAN Cloud Acquisition
Aryaka23.10.2018 15:01 | pressemeddelelse
Aryaka Announces Expanded Cloud Offerings with Oracle FastConnect
Cloudstreet23.10.2018 10:01 | pressemeddelelse
Must Read Whitepaper, ‘Making Money With Network Slicing’, Hits The Shelves
Paysafe Group22.10.2018 15:01 | pressemeddelelse
Paysafe’s Differentiated Solutions and Customer Service Recognized by Independent Research Firm
Mitratech22.10.2018 15:01 | pressemeddelelse
Mitratech Announces TeamConnect Essentials for Mid-Sized Legal Departments
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum